Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-35,286
Closed -$30.7M 55
2020
Q1
$30.7M Sell
35,286
-24,403
-41% -$24.3M 3.2% 12
2019
Q4
$64M Buy
59,689
+7,937
+15% +$8.1M 5.77% 4
2019
Q3
$47.8M Sell
51,752
-8,719
-14% -$9.58M 6.04% 7
2019
Q2
$68.3M Buy
60,471
+53,736
+798% +$58.8M 6.9% 5
2019
Q1
$9.15M Sell
6,735
-54,247
-89% -$73.6M 0.84% 29
2018
Q4
$70.6M Sell
60,982
-19,708
-24% -$22.2M 7.06% 3
2018
Q3
$123M Hold
80,690
11.04% 1
2018
Q2
$126M Buy
80,690
+593
+0.7% +$773K 12.02% 1
2018
Q1
$92.5M Sell
80,097
-1,812
-2% -$2.39M 9.28% 3
2017
Q4
$97.1M Buy
81,909
+12,482
+18% +$15.7M 10.93% 2
2017
Q3
$93.4M Buy
69,427
+6,009
+9% +$6.33M 12.45% 2
2017
Q2
$51.2M Buy
63,418
+61,738
+3,675% +$43M 9.09% 4
2017
Q1
$1.04M Sell
1,680
-25,767
-94% -$15.7M 0.26% 25
2016
Q4
$14.7M Hold
27,447
4.67% 10
2016
Q3
$14.2M Sell
27,447
-4,103
-13% -$1.93M 4.36% 9
2016
Q2
$12.9M Sell
31,550
-3,000
-9% -$1.37M 5.1% 6
2016
Q1
$18.4M Sell
34,550
-14,109
-29% -$7.03M 6.43% 4
2015
Q4
$37.1M Sell
48,659
-557
-1% -$370K 11.64% 1
2015
Q3
$27M Buy
49,216
+1,000
+2% +$606K 12.28% 1
2015
Q2
$28.3M Buy
48,216
+32,216
+201% +$18.7M 9.44% 4
2015
Q1
$12.6M Hold
16,000
4.18% 11
2014
Q4
$10.9M Buy
+16,000
New +$10.3M 5.53% 7

Other funds holding KYNB

EcoR1 Capital's KYNB Position: Q2 2020 in Review

EcoR1 Capital sold out of Kyntra Bio (KYNB) in Q2 2020, closing a stake of 35,286 shares — an estimated $30.7M sold.

EcoR1 Capital first reported a position in KYNB in Q4 2014 and held it in 22 quarters. The position peaked at $126M in Q2 2018. 194 funds tracked by Wall St. Rank hold KYNB as of Q2 2020.

  • EcoR1 Capital reported no remaining Kyntra Bio position as of Q2 2020 after selling out during the quarter.
  • EcoR1 Capital sold 35,286 Kyntra Bio shares in Q2 2020, an estimated $30.7M.
  • EcoR1 Capital first reported a position in Kyntra Bio in Q4 2014 and held it in 22 quarters.
  • EcoR1 Capital's Kyntra Bio position peaked at $126M in Q2 2018.
  • 194 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2020.

Based on EcoR1 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.